Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Olaparib Diffuse Intrinsic Pontine Glioma	Fundación de investigación HM	P1/2	CCC (48)
Olaparib Carcinoma	The Netherlands Cancer Institute	P1/2	CCC (48)
Olaparib Neuroendocrine Neoplasm	Fundación de investigación HM	P1/2	CCC (48)
Olaparib Ovarian Serous Surface Papillary Adenocarcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Olaparib Pheochromocytoma-Paraganglioma	Fundación de investigación HM	P1/2	CCC (48)
Olaparib Synovial Sarcoma	Fundación de investigación HM	P1/2	CCC (48)
Olverembatinib Acute Myeloid Leukemia	Ascentage Pharma Group Inc.	P1/2	CCC (48)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter Malignant Ovarian Brenner Tumor	Mayo Clinic	P1/2	CCC (48)
Oncolytic Virus Rp1 Basal Cell Carcinoma	Replimune, Inc.	P1/2	CCC (48)
Oncolytic Virus Rp1 Skin Squamous Cell Carcinoma	Replimune, Inc.	P1/2	CCC (48)
Onc-Plureceptor Nk Cells B-Cell Non-Hodgkin Lymphoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
Onct-808 Aggressive B-Cell Non-Hodgkin Lymphoma	Oncternal Therapeutics, Inc	P1/2	CCC (48)
Onivyde Ewing Sarcoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Hepatoblastoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Malignant Germ Cell Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Neuroblastoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Osteosarcoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Peripheral Primitive Neuroectodermal Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Rhabdoid Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Rhabdomyosarcoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Soft Tissue Sarcoma	St. Jude Children's Research Hospital	P1/2	CCC (48)
Onivyde Wilms Tumor	St. Jude Children's Research Hospital	P1/2	CCC (48)
Opnurasib Lung Cancer	Novartis Pharmaceuticals	P1/2	CCC (48)
Opnurasib Colorectal Carcinoma	Novartis Pharmaceuticals	P1/2	CCC (48)
Opnurasib Lung Neoplasm	Novartis Pharmaceuticals	P1/2	CCC (48)

Showing 1551 to 1575 of 6,308 assets

PreviousPage 63 of 253Next